QUOTE AND NEWS
The Hindu Business Line  4 hrs ago  Comment 
The Greece-Eurozone crisis is expected to have a lesser impact on the Indian economy than expected. Ranjit Shahani, Vice Chairman and Managing Director, Novartis India, insists that a bigger crisi...
Benzinga  Jul 2  Comment 
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced...
FiercePharma  Jul 1  Comment 
Kickback allegations against Novartis just got scarier. After years of investigating the Swiss drugmaker, the Justice Department and 11 states are demanding almost $3.4 billion in damages and fines in a False Claims Act lawsuit nearing trial.
TheStreet.com  Jun 30  Comment 
NEW YORK (TheStreet) -- Novartis AG shares are down 0.42% to $98.11 in afternoon trading on Tuesday after the U.S. government filed papers saying that the company should pay fines of up to $3.35 billion over the alleged kickbacks the company...
FiercePharma  Jun 30  Comment 
Novartis has big plans for its much-anticipated heart failure remedy Entresto. The Swiss drugmaker figures it can parlay impressive trial data on the drug into its biggest launch in years--perhaps ever.
newratings.com  Jun 30  Comment 
Novartis Pharmaceuticals launches the first app for visually impaired people for use with the Apple Watch and other smart watches Novartis International AG / Novartis Pharmaceuticals launches the first app for visually impaired people for use...
GenEng News  Jun 29  Comment 
Novartis will acquire pain drug developer Spinifex Pharmaceuticals for $200 million cash upfront plus undisclosed clinical development and regulatory milestone payments, the companies said today. The deal will expand Novartis’ neuroscience...
The Australian  Jun 29  Comment 
FierceBiotech  Jun 29  Comment 
A little more than a year ago, Melbourne, Australia-based Spinifex decided to take part of a $45 million round to set up an office in Stamford, CT, with the clear intention of putting its mid-stage pain drug in a better position on Big Pharma's...
newratings.com  Jun 29  Comment 
Novartis deepens its industry leading pipeline with acquisition of Spinifex Pharmaceuticals, Inc. Novartis International AG / Novartis deepens its industry leading pipeline with acquisition of Spinifex Pharmaceuticals, Inc. . Processed and...
newratings.com  Jun 29  Comment 
BASEL (dpa-AFX) - Swiss drug giant Novartis AG (NVS) said Monday that new trial results showed Cosentyx or secukinumab was significantly superior to placebo and also showed sustained efficacy over one year in psoriatic arthritis patients. The new,...




 

Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki